Guillain-Barré Syndrome following Treatment with Sunitinib Malate

Guillain-Barré Syndrome following Treatment with Sunitinib Malate

Sunitinib malate (Sutent, SU011248) is an oral multitargeted tyrosine kinase inhibitor (TKI) used for the treatment of metastatic renal cell carcinoma and imatinib (Gleevec)—resistant gastrointestinal stromal tumor (GIST) with few reported side effects including asthenia, myelosuppression, diarrhea,...

Full description

Bibliographic Details
Main Authors: Kanaan, Ziad, Kulairi, Zain, Titianu, Mirela, Saha, Sandip, Kumar, Sarwan
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074976/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074976/

Similar Items